Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits

Pharmacological Research

Volumn 109, Issue , 2016, Pages 108-118

  Bisagno, Veronica ^a   González, Betina ^a   Urbano, Francisco J ^b  

^a Instituto de Investigaciones Farmacologicas   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Calcium channels; Cocaine; Dopamine; Hyperpolarization activated cation current; Methamphetamine; Methylphenidate; Modafinil; Prefrontal cortex

Indexed keywords

AMPA RECEPTOR; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; CALCIUM ION; COCAINE; DELAYED RECTIFIER POTASSIUM CHANNEL; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL; METABOTROPIC RECEPTOR; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; VOLTAGE GATED CALCIUM CHANNEL; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; NOOTROPIC AGENT;

BRAIN FUNCTION; CALCIUM TRANSPORT; COGNITION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; DRUG MECHANISM; HUMAN; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCHIZOPHRENIA; ANIMAL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; HUMANS; METHAMPHETAMINE; METHYLPHENIDATE; NOOTROPIC AGENTS; PREFRONTAL CORTEX; SUBSTANCE-RELATED DISORDERS;

EID: 84971455372     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.01.013     Document Type: Review

References (165)

1. D. Repantis, P. Schlattmann, O. Laisney, and I. Heuser Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review Pharmacol. Res. 62 3 2010 187 206
2. B. Maher Poll results: look who's doping Nature 452 7188 2008 674 675
3. R.M. Battleday, and A.K. Brem Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review Eur. Neuropsychopharmacol. 25 11 2015 1865 1881
4. E.S. Bromberg-Martin, M. Matsumoto, and O. Hikosaka Dopamine in motivational control: rewarding, aversive, and alerting Neuron 68 5 2010 815 834
5. R.Z. Goldstein, and N.D. Volkow Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications Nat. Rev. Neurosci. 12 11 2011 652 669
6. M.J. Minzenberg, and C.S. Carter Modafinil: a review of neurochemical actions and effects on cognition Neuropsychopharmacology 33 7 2008 1477 1502
7. M. Mere, A. Bonci, A.H. Newman, and G. Tanda The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders Psychopharmacology (Berlin) 229 3 2013 415 434
8. D. Zolkowska, R. Jain, R.B. Rothman, J.S. Partilla, B.L. Roth, V. Setola, T.E. Prisinzano, and M.H. Baumann Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil J. Pharmacol. Exp. Ther. 329 2 2009 738 746
9. B.K. Madras, Z. Xie, Z. Lin, A. Jassen, H. Panas, L. Lynch, R. Johnson, E. Livni, T.J. Spencer, A.A. Bonab, G.M. Miller, and A.J. Fischman Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro J. Pharmacol. Exp. Ther. 319 2 2006 561 569
10. L. Scoriels, P.B. Jones, and B.J. Sahakian Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain Neuropharmacology 64 2013 168 184
11. F.J. Urbano, E. Leznik, and R.R. Llinás Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling Proc. Natl. Acad. Sci. U. S. A 104 2007 12554 12559
12. M. Raineri, V. Peskin, B. Goitia, I.R. Taravini, S. Giorgeri, F.J. Urbano, and V. Bisagno Attenuated methamphetamine induced neu- rotoxicity by modafinil administration in mice Synapse 65 10 2011 1087 1098
13. M. Raineri, B. Gonzalez, B. Goitia, E. Garcia-Rill, I.N. Krasnova, J.L. Cadet, F.J. Urbano, and V. Bisagno Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum PLoS One 7 10 2012 e46599
14. J.P. Lindenmayer, H. Nasrallah, M. Pucci, S. James, and L. Citrome A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities Schizophr. Res. 147 2-3 2013 241 252
15. O. Gruber, A. Chadha Santuccione, and H. Aach Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system Front. Psychiatry 5 2014 32
16. C. Andrade, S. Kisely, I. Monteiro, and S. Rao Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: systematic review and meta-analysis of randomized controlled trials J. Psychiatr. Res. 60 2015 14 21
17. S. Wood, J.R. Sage, T. Shuman, and S.G. Anagnostaras Psychostimulants and cognition: a continuum of behavioral and cognitive activation Pharmacol. Rev. 66 1 2013 193 221
18. S.V. Faraone, J. Biederman, T. Spencer, E. Mick, K. Murray, C. Petty, J.J. Adamson, and M.C. Monuteaux Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am. J. Psychiatry 163 10 2006 1720 1729
19. J. Biederman, and S.V. Faraone The effects of attention-deficit/hyperactivity disorder on employment and household income Med. Gen. Med. 8 3 2006 12
20. S.J. Kooij, S. Bejerot, A. Blackwell, H. Caci, M. Casas-Brugué, P.J. Carpentier, D. Edvinsson, J. Fayyad, K. Foeken, M. Fitzgerald, V. Gaillac, Y. Ginsberg, and et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD BMC Psychiatry 10 2010 67
21. V. Engert, and J.C. Pruessner Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate Curr. Neuropharmacol. 6 4 2008 322 328
22. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J. Neurochem. 68 5 1997 2032 2037
23. J.S. Markowitz, C.L. DeVane, L.K. Pestreich, K.S. Patrick, and R.A. Muniz Comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study J. Child Adolesc. Psychopharmacol. 16 6 2006 687 698
24. V. Sandoval, E.L. Riddle, G.R. Hanson, and A.E. Fleckenstein Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits J. Pharmacol. Exp. Ther. 304 3 2003 1181 1187
25. N.D. Volkow, G.J. Wang, Y. Ma, J.S. Fowler, C. Wong, Y.S. Ding, R. Hitzemann, J.M. Swanson, and P. Kalivas Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction J. Neurosci. 25 15 2005 3932 3939
26. J.S. Fowler, N.D. Volkow, J. Logan, D. Alexoff, F. Telang, G.J. Wang, C. Wong, Y. Ma, A. Kriplani, K. Pradhan, D. Schlyer, M. Jayne, B. Hubbard, P. Carter, D. Warner, P. King, C. Shea, Y. Xu, L. Muench, and K. Apelskog Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine Neuroimage 43 4 2008 756 763
27. G.M. Bright Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey Medscape J. Med. 10 5 2008 111
28. E. Frauger, D. Amaslidou, M. Spadari, V. Allaria-Lapierre, D. Braunstein, V. Sciortino, X. Thirion, S. Djezzar, and J. Micallef Patterns of methylphenidate use and assessment of its abuse among the general population and individuals with drug dependence Eur. Addict. Res. 22 3 2016 119 126
29. K.L. Humphreys, T. Eng, and S.S. Lee Stimulant medication and substance use outcomes: a meta-analysis JAMA Psychiatry 70 7 2013 740 749
30. S. Dalsgaard, P.B. Mortensen, M. Frydenberg, and P.H. Thomsen ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study Addict. Behav. 39 1 2014 325 328
31. J.L. Breyer, S. Lee, K.C. Winters, G.J. August, and G.M. Realmuto A longitudinal study of childhood ADHD and substance dependence disorders in early adulthood Psychol. Addict. Behav. 28 1 2014 238 246
32. D.R. Jasinski An evaluation of the abuse potential of modafinil using methylphenidate as a reference J. Psychopharmacol. 14 1 2000 53 60
33. C.R. Rush, T.H. Kelly, L.R. Hays, and A.F. Wooten Discriminative-stimulus effects of modafinil in cocaine-trained humans Drug Alcohol Depend. 67 3 2002 311 322
34. N.D. Volkow, G.J. Wang, J.S. Fowler, and D. Tomasi Addiction circuitry in the human brain Annu. Rev. Pharmacol. Toxicol. 52 2012 321 336
35. J.L. Cadet, V. Bisagno, and C.M. Milroy Neuropathology of substance use disorders Acta Neuropathol. 127 2014 91 107
36. M.E. Rice, and S.J. Cragg Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway Brain Res. Rev. 58 2008 303 313
37. S.B. Ross, and A.L. Renyi Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue Eur. J. Pharmacol. 7 3 1969 270 277
38. M.C. Wilson, J.A. Bedford, J. Buelke, and A.H. Kibbe Acute pharmacological activity of intravenous cocaine in the rhesus monkey Psychopharmacol. Commun. 2 1976 251 261
39. M.H. Baumann, and R.B. Rothman Chronic cocaine exposure potentiates prolactin and head shake responses to 5-HT2 receptor stimulation in rats Neuropharmacology 35 3 1996 295 301
40. M. Filip, E. Nowak, and I. Papla On the role of serotonin2A/2C receptors in the sensitization to cocaine J. Physiol. Pharmacol. 52 3 2001 471 481
41. P.J. Fletcher, A.J. Grottick, and G.A. Higgins Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding Neuropsychopharmacology 27 4 2002 576 586
42. J.J. Burmeister, E.M. Lungren, K.F. Kirschner, and J.L. Neisewander Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats Neuropsychopharmacology 29 4 2004 660 668
43. C.C. Huang, Y.C. Liang, C.C. Lee, M.Y. Wu, and K.S. Hsu Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex Neuropsychopharmacology 34 8 2009 1979 1992
44. B. Goitia, M. Raineri, L.E. González, J.L. Rozas, E. Garcia-Rill, V. Bisagno, and F.J. Urbano Differential effects of methylphenidate and cocaine on GABA transmission in sensory thalamic nuclei J. Neurochem. 124 5 2013 602 612
45. B. Goitia, M.C. Rivero-Echeto, N.V. Weisstaub, J.A. Gingrich, E. Garcia-Rill, V. Bisagno, and F.J. Urbano Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors J. Neurochem. 136 3 2016 526 535
46. D. Sulzer, and S. Rayport Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action Neuron 5 6 1990 797 808
47. D. Sulzer, M.S. Sonders, N.W. Poulsen, and A. Galli Mechanisms of neurotransmitter release by amphetamines: a review Prog. Neurobiol. 75 6 2005 406 433
48. M. Johnson, P.K. Sonsalla, A.A. Letter, G.R. Hanson, and J.W. Gibb Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations J. Pharmacol. Exp. Ther. 270 1 1994 97 103
49. U.V. Berger, X.F. Gu, and E.C. Azmitia The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine Eur. J. Pharmacol. 215 2-3 1992 153 160
50. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U. S. A. 85 14 1988 5274 5278
51. S.E. Hyman Addiction: a disease of learning and memory Am. J. Psychiatry 162 8 2005 1414 1422
52. N.J. Gamo, G. Lur, M.J. Higley, M. Wang, C.D. Paspalas, S. Vijayraghavan, Y. Yang, B.P. Ramos, K. Peng, A. Kata, L. Boven, F. Lin, L. Roman, D. Lee, and A.F. Arnsten Stress impairs prefrontal cortical function via D1 dopamine receptor interactions with hyperpolarization-activated cyclic nucleotide-gated channels Biol. Psychiatry 78 12 2015 860 870
53. R.A. Wise Drive incentive, and reinforcement: the antecedents and consequences of motivation Neb. Symp. Motiv. 50 2004 159 195
54. R.A. Wise Dual roles of dopamine in food and drug seeking: the drive-reward paradox Biol. Psychiatry 73 9 2013 819 826
55. K.C. Berridge, and T.E. Robinson What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Rev. 28 3 1998 309 369
56. K.C. Berridge, and M.L. Kringelbach Pleasure systems in the brain Neuron 86 3 2015 646 664
57. W. Schultz Multiple dopamine functions at different time courses Annu. Rev. Neurosci. 30 2007 259 288
58. A.A. Grace, S.B. Floresco, Y. Goto, and D.J. Lodge Regulation of firing of dopaminergic neurons and control of goal-directed behaviors Trends Neurosci. 30 5 2007 220 227
59. J.D. Barchas, H. Akil, G.R. Elliott, R.B. Holman, and S.J. Watson Behavioral neurochemistry: neuroregulators and behavioral states Science 200 4344 1978 964 973
60. S.J. Cragg, C. Nicholson, J. Kume-Kick, L. Tao, and M.E. Rice Dopamine-mediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake J. Neurophysiol. 85 4 2001 1761 1771
61. M.E. Rice, and J.C. Patel Somatodendritic dopamine release: recent mechanistic insights Philos. Trans. R. Soc. Lond. B. Biol. Sci. 370 1672 2015 pii: 20140185
62. N.X. Tritsch, and B.L. Sabatini Dopaminergic modulation of synaptic transmission in cortex and striatum Neuron 76 1 2012 33 50
63. J.M. Beaulieu, and R.R. Gainetdinov The physiology, signaling, and pharmacology of dopamine receptors Pharmacol. Rev. 63 1 2011 182 217
64. C.C. Felder, P.A. Jose, and J. Axelrod The dopamine-1 agonist SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase J. Pharmacol. Exp. Ther. 248 1989 171 175
65. E. Friedman, L.Q. Jin, G.P. Cai, T.R. Hollon, J. Drago, D.R. Sibley, and H.Y. Wang D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice Mol. Pharmacol. 51 1 1997 6 11
66. A. Sahu, K.R. Tyeryar, H.O. Vongtau, D.R. Sibley, and A.S. Undieh D5 dopamine receptors are required for dopaminergic activation of phospholipase C Mol. Pharmacol. 75 2009 447 453
67. S.P. Lee, C.H. So, A.J. Rashid, G. Varghese, R. Cheng, A.J. Lança, B.F. O'Dowd, and S.R. George Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal J. Biol. Chem. 279 2004 35671 35678
68. A.J. Rashid, C.H. So, M.M. Kong, T. Furtak, M. El-Ghundi, R. Cheng, B.F. O'Dowd, and S.R. George D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum Proc. Natl. Acad. Sci. U. S. A. 104 2 2007 654 659
69. C. De Mei, M. Ramos, C. Iitaka, and E. Borrelli Getting specialized: presynaptic and postsynaptic dopamine D2 receptors Curr. Opin. Pharmacol. 9 1 2009 53 58
70. P. Sokoloff, J. Diaz, B. Le Foll, O. Guillin, L. Leriche, E. Bezard, and C. Gross The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders CNS Neurol. Disord. Drug Targets 5 1 2006 25 43
71. M. Bentivoglio, and M. Morelli The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain S.B. Dunnett, M. Bentivoglio, A. Bjorklund, T. Hokfelt, Dopamine 2005 Elsevier San Diego, CA 1 107
72. P.S. Goldman-Rakic, S.A. Castner, T.H. Svensson, L.J. Siever, and G.V. Williams Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction Psychopharmacology (Berlin) 174 1 2004 3 16
73. M.S. Lidow, P.S. Goldman-Rakic, D.W. Gallager, and P. Rakic Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using 3H raclopride, 3H spiperone and 3H SCH23390 Neuroscience 40 1991 657 671
74. C. Bergson, L. Mrzljak, J.F. Smiley, M. Pappy, R. Levenson, and P.S. Goldman-Rakic Regional cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain J. Neurosci. 15 1995 7821 7836
75. E.C. Muly 3rd, K. Szigeti, and P.S. Goldman-Rakic D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization J. Neurosci. 18 1998 10553 10565
76. F. Liu, Q. Wan, Z.B. Pristupa, X.M. Yu, Y.T. Wang, and H.B. Niznik Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors Nature 403 6767 2000 274 280
77. W.J. Gao, L.S. Krimer, and P.S. Goldman-Rakic Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits Proc. Natl. Acad. Sci. U.S.A. 98 2001 295 300
78. J.K. Seamans, D. Durstewitz, B.R. Christie, C.F. Stevens, and T.J. Sejnowski Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons Proc. Natl. Acad. Sci. U.S.A. 98 2001 301 306
79. L. Mrzljak, C. Bergson, M. Pappy, R. Huff, R. Levenson, and P.S. Goldman-Rakic Localization of dopamine D4 receptors in GABAergic neurons of the primate brain Nature 381 1996 245 248
80. W.D. Yao, R.D. Spealman, and J. Zhang Dopaminergic signaling in dendritic spines Biochem. Pharmacol. 75 11 2008 2055 2069
81. P.S. Goldman-Rakic, C. Leranth, S.M. Williams, N. Mons, and M. Geffard Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex Proc. Natl. Acad. Sci. U.S.A. 86 22 1989 9015 9019
82. M.E. Larkum, J.J. Zhu, and B. Sakmann A new cellular mechanism for coupling inputs arriving at different cortical layers Nature 398 6725 1999 338 341
83. J.K. Seamans, D. Durstewitz, B.R. Christie, C.F. Stevens, and T.J. Sejnowski Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons Proc. Natl. Acad. Sci. U.S.A. 98 2001 301 306
84. C. Gonzalez-Islas, and J.J. Hablitz Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex J. Neurosci. 23 2003 867 875
85. X. Sun, Y. Zhao, and M.E. Wolf Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons J. Neurosci. 25 2005 7342 7351
86. C. Gao, and M.E. Wolf Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons J. Neurochem. 106 2008 2489 2501
87. H. Gurden, M. Takita, and T.M. Jay Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo J. Neurosci. 20 2000 RC106
88. Y.Y. Huang, E. Simpson, C. Kellendonk, and E.R. Kandel Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors Proc. Natl. Acad. Sci. U.S.A. 101 2004 3236 3241
89. C. Cepeda, and M.S. Levine Where do you think you are going? The NMDA-D1 receptor trap Sci. STKE 333 2006 pe. 20
90. D.W. Choi Glutamate neurotoxicity and diseases of the nervous system Neuron 1 1988 623 634
91. Y. Bozzi, and E. Borrelli Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it Trends Neurosci. 29 2006 167 174
92. 2+ signaling in neurons Cell Calcium 24 5-6 1998 359 366
93. E.M. Kawamoto, C. Vivar, and S. Camandola Physiology and pathology of calcium signaling in the brain Front. Pharmacol. 3 2012 1 17
94. 2+ potentials via differential protein kinase A and C activation in rat prefrontal cortical neurons J. Neurosci. 24 1 2004 8 23
95. A.E. Kisilevsky, S.J. Mulligan, C. Altier, M.C. Iftinca, D. Varela, C. Tai, L. Chen, S. Hameed, J. Hamid, B.A. Macvicar, and G.W. Zamponi D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry Neuron 58 2008 557 570
96. H.W. Tedford, and G.W. Zamponi Direct G protein modulation of Cav2 calcium channels Pharmacol. Rev. 58 4 2006 837 862
97. A.C. Dolphin G protein modulation of voltage-gated calcium channels Pharmacol. Rev. 55 4 2003 607 627
98. + channel slow inactivation via cAMP-dependent protein kinase and protein kinase C Neuron 49 2006 409 420
99. C.R. Yang, and J.S. Seamans Dopamine D1 receptor actions in layer V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration J. Neurosci. 16 1996 1922 1935
100. S. Kroener, L.J. Chandler, P.E. Phillips, and J.K. Seamans Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex PLoS One 4 8 2009 e6507
101. S. Vijayraghavan, M. Wang, S.G. Birnbaum, G.V. Williams, and A.F. Arnsten Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory Nat. Neurosci. 10 3 2007 376 384
102. C. He, F. Chen, B. Li, and Z. Hu Neurophysiology of HCN channels: from cellular functions to multiple regulations Prog. Neurobiol. 112 2014 1 23
103. M. Wang, B.P. Ramos, C.D. Paspalas, Y. Shu, A. Simen, A. Duque, and et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex Cell 129 2007 397 410
104. S. Chen, J. Wang, and S.A. Siegelbaum Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide J. Gen. Physiol. 117 2001 491 504
105. C. Ulens, and J. Tytgat Functional heteromerization of HCN1 and HCN2 pacemaker channels J. Biol. Chem. 276 2001 6069 6072
106. T. Notomi, and R. Shigemoto Immunohistochemical localization of Ih channel subunits HCN1-4, in the rat brain J. Comp. Neurol. 471 2004 241 276
107. B. Santos-Vera, R. Vázquez-Torres, H.G. Marrero, J.M. Acevedo, F. Arencibia-Albite, M.E. Vélez-Hernández, J.D. Miranda, and C.A. Jiménez-Rivera Cocaine sensitization increases Ih current channel subunit 2 (HCN2) protein expression in structures of the mesocorticolimbic system J. Mol. Neurosci. 50 2013 234 245
108. B. Santoro, S. Chen, A. Luthi, P. Pavlidis, G.P. Shumyatsky, G.R. Tibbs, and S.A. Siegelbaum Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS J. Neurosci. 20 2000 5264 5275
109. A. Lörincz, T. Notomi, G. Tamás, R. Shigemoto, and Z. Nusser Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites Nat. Neurosci. 5 2002 1185 1193
110. T. Berger, W. Senn, and H.R. Lüscher Hyperpolarization-activated current Ih disconnects somatic and dendritic spike initiation zones in layer V pyramidal neurons J. Neurophysiol. 90 4 2003 2428 2437
111. J. Wu, and J.J. Hablitz Cooperative activation of D1 and D2 dopamine receptors enhances a hyperpolarization-activated inward current in layer I interneurons J. Neurosci. 25 27 2005 6322 6328
112. A.F. Arnsten Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia Int. J. Dev. Neurosci. 29 2011 215 223
113. M.F. Nolan, G. Malleret, J.T. Dudman, D.L. Buhl, B. Santoro, E. Gibbs, S. Vronskaya, G. Buzsáki, S.A. Siegelbaum, E.R. Kandel, and A. Morozov A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons Cell 119 2004 719 732
114. J.C. Magee Dendritic lh normalizes temporal summation in hippocampal CA1 neurons Nat. Neurosci. 2 1999 508 514
115. D.C. Rotaru, D.A. Lewis, and G. Gonzalez-Burgos Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons J. Physiol. 581 Pt 3 2007 981 1000
116. N. Gorelova, J.K. Seamans, and C.R. Yang Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex J. Neurophysiol. 88 6 2002 3150 3166
117. Y. Dong, D. Cooper, F. Nasif, X.T. Hu, and F.J. White Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons J. Neurosci. 24 12 2004 3077 3085
118. G. Witkowski, B. Szulczyk, R. Rola, and P. Szulczyk D(1) dopaminergic control of G protein-dependent inward rectifier K(+) (GIRK)-like channel current in pyramidal neurons of the medial prefrontal cortex Neuroscience 155 1 2008 53 63
119. N. Maurice, T. Tkatch, M. Meisler, L.K. Sprunger, and D.J. Surmeier D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons J. Neurosci. 21 7 2001 2268 2277
120. J.D. Peterson, M.E. Wolf, and F.J. White Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex J. Neurosci. 26 2006 3164 3168
121. + currents increases the excitability of rat neocortical pyramidal neurones J. Physiol. 528 2000 291 304
122. P.S. Goldman-Rakic, E.C. 3rd. Muly, and G.V. Williams D(1) receptors in prefrontal cells and circuits Brain Res. Brain Res. Rev. 31 2-3 2000 295 301
123. P.S. Goldman-Rakic, S.A. Castner, T.H. Svensson, L.J. Siever, and G.V. Williams Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction Psychopharmacology (Berlin) 174 1 2004 3 16
124. R. De Jongh, I. Bolt, M. Schermer, and B. Oliver Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories Neurosci. Biobehav. Rev. 32 4 2008 760 776
125. G.L. Lin, C.B. Borders, L.J. Lundewall, and C.L. Wellman D1 receptors regulate dendritic morphology in normal and stressed prelimbic cortex Psychoneuroendocrinology 51 2015 101 111
126. R.D. Mair, and J.A. Kauer Amphetamine depresses excitatory synaptic transmission at prefrontal cortical layer V synapses Neuropharmacology 52 2007 193 199
127. C.W. Berridge, D.M. Devilbiss, M.E. Andrzejewski, A.F. Arnsten, A.E. Kelley, B. Schmeichel, C. Hamilton, and R.C. Spencer Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol. Psychiatry 60 10 2006 1111 1120
128. G.D. Andrews, and A. Lavin Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors Neuropsychopharmacology 31 3 2006 594 601
129. D.M. Devilbiss, and C.W. Berridge Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness Biol. Psychiatry 64 7 2008 626 635
130. K.R. Urban, B.D. Waterhouse, and W.J. Gao Distinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons Biol. Psychiatry 72 10 2012 880 888
131. E.Y. Joo, W.S. Tae, K.Y. Jung, and S.B. Hong Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study J. Sleep Res. 17 1 2008 82 88
132. M. Saletu, P. Anderer, H.V. Semlitsch, G.M. Saletu-Zyhlarz, M. Mandl, J. Zeitlhofer, and B. Saletu Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy Psychiatry Res. 154 1 2007 69 84
133. M.D. Hunter, V. Ganesan, I.D. Wilkinson, and S.A. Spence Impact of modafinil on prefrontal executive function in schizophrenia Am. J. Psychiatry 163 12 2006 2184 2186
134. S.A. Spence, R.D. Green, I.D. Wilkinson, and M.D. Hunter Modafinil modulates anterior cingulate function in chronic schizophrenia Br. J. Psychiatry 187 2005 55 61
135. A. Gozzi, V. Colavito, P.F. Seke Etet, D. Montanari, S. Fiorini, S. Tambalo, A. Bifone, G.G. Zucconi, and M. Bentivoglio Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat Neuropsychopharmacology 37 3 2012 822 837
136. M.J. Minzenberg, and C.S. Carter Modafinil: a review of neurochemical actions and effects on cognition Neuropsychopharmacology 33 7 2008 1477 1502
137. H.L. Rowley, R.S. Kulkarni, J. Gosden, R.J. Brammer, D. Hackett, and D.J. Heal Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats J. Psychopharmacol. 28 3 2014 254 269
138. B. Gonzalez, M. Raineri, J.L. Cadet, E. Garcia-Rill, F.J. Urbano, and V. Bisagno Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice Neuropharmacology 87 2014 188 197
139. H. Kamei, T. Nagai, H. Nakano, Y. Togan, M. Takayanagi, K. Takahashi, K. Kobayashi, S. Yoshida, K. Maeda, K. Takuma, T. Nabeshima, and K. Yamada Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice Biol. Psychiatry 59 2006 75 84
140. T. Nagai, K. Takuma, M. Dohniwa, D. Ibi, H. Mizoguchi, H. Kamei, T. Nabeshima, and K. Yamada Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol Psychopharmacology (Berlin) 194 1 2007 21 32
141. E. Valjent, J.C. Corvol, C. Pages, M.J. Besson, R. Maldonado, and J. Caboche Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties J. Neurosci. 20 23 2000 8701 8709
142. J.W. Young, and M.A. Geyer Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors? Biol. Psychiatry 67 8 2010 784 787
143. J.L. Cadet, and V. Bisagno Neuropsychological consequences of chronic drug use: relevance to treatment approaches Front. Psychiatry 6 2016 189
144. D. Tomasi, R.Z. Goldstein, F. Telang, T. Maloney, N. Alia-Klein, E.C. Caparelli, and N.D. Volkow Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence Brain Res. 1171 2007 83 92
145. R.Z. Goldstein, A.C. Leskovjan, A.L. Hoff, R. Hitzemann, F. Bashan, S.S. Khalsa, G.J. Wang, J.S. Fowler, and N.D. Volkow Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex Neuropsychologia 42 11 2004 1447 1458
146. J. Camchong, A.W. MacDonald 3rd, B. Nelson, C. Bell, B.A. Mueller, S. Specker, and K.O. Lim Frontal hyperconnectivity related to discounting and reversal learning in cocaine subjects Biol. Psychiatry 69 11 2011 1117 1123
147. A. Barrós-Loscertales, J.C. Bustamante, N. Ventura-Campos, J.J. Llopis, M.A. Parcet, and C. Avila Lower activation in the right frontoparietal network during a counting Stroop task in a cocaine-dependent group Psychiatry Res. 194 2 2011 111 118
148. K.I. Bolla, D.A. Eldreth, E.D. London, K.A. Kiehl, M. Mouratidis, C. Contoreggi, J.A. Matochik, V. Kurian, J.L. Cadet, A.S. Kimes, F.R. Funderburk, and M. Ernst Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task Neuroimage 19 3 2003 1085 1094
149. A. Bechara The role of emotion in decision-making: evidence from neurological patients with orbitofrontal damage Brain Cogn. 55 1 2004 30 40
150. B.T. Chen, H.J. Yau, C. Hatch, I. Kusumoto-Yoshida, S.L. Cho, F.W. Hopf, and A. Bonci Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking Nature 496 7445 2013 359 362
151. W.N. Wayman, L. Chen, T.C. Napier, and X.T. Hu Cocaine self-administration enhances excitatory responses of pyramidal neurons in the rat medial prefrontal cortex to human immunodeficiency virus-1 Tat Eur. J. Neurosci. 41 9 2015 1195 1206
152. M.P. Paulus, N.E. Hozack, B.E. Zauscher, L. Frank, G.G. Brown, and D.L. Braff Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects Neuropsychopharmacology 26 2002 53 63
153. L. Chang, C. Cloak, K. Patterson, C. Grob, E.N. Miller, and T. Ernst Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response Biol. Psychiatry 57 2005 967 974
154. E.D. London, S.M. Berman, B. Voytek, S.L. Simon, M.A. Mandelkern, J. Monterosso, and et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers Biol. Psychiatry 58 2005 770 778
155. C.-E. Johanson, K.A. Frey, L.H. Lundahl, P. Keenan, N. Lockhart, J. Roll, and et al. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers Psychopharmacology 185 2006 327 338
156. J.R. Monterosso, G. Ainslie, J. Xu, X. Cordova, C.P. Domier, and E.D. London Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task Hum. Brain Mapp. 28 2007 383 393
157. W.F. Hoffman, M. Moore, R. Templin, B. McFarland, R.J. Hitzemann, and S.H. Mitchell Neuropsychological function and delay discounting in methamphetamine-dependent individuals Psychopharmacology 188 2006 162 170
158. L.J. Nestor, D.G. Ghahremani, J. Monterosso, and E.D. London Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects Psychiatry Res. 194 2011 287 295
159. A. Parsegian, and R.E. See Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats Neuropsychopharmacology 39 2014 811 822
160. R. Salo, S. Ursu, M.H. Buonocore, M.H. Leamon, and C. Carter Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: a functional magnetic resonance imaging study Biol. Psychiatry 65 2009 706 709
161. 2+ currents and excitatory synaptic transmission through D1 /5 receptor-mediated mechanisms in the mouse medial prefrontal cortex Addict. Biol. 2015 (in press)
162. W.L. Zhou, and S.D. Antic Rapid dopaminergic and GABAergic modulation of calcium and voltage transients in dendrites of prefrontal cortex pyramidal neurons J. Physiol. 590 Pt 16 2012 3891 3911
163. K.M. Dürsteler, E.M. Berger, J. Strasser, C. Caflisch, J. Mutschler, M. Herdener, and M. Vogel Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence Subst. Abuse Rehabil. 2016 (in press)
164. C. Pérez-Mañá, X. Castells, M. Torrens, D. Capellà, and M. Farre Efficacy of psychostimulant drugs for amphetamine abuse or dependence Cochrane Database Syst. Rev. 9 2013 CD009695
165. X. Castells, M. Casas, C. Pérez-Mañá, C. Roncero, X. Vidal, and D. Capellà Efficacy of psychostimulant drugs for cocaine dependence Cochrane Database Syst Rev. 2 2010 CD007380